South and Central America Adenosine Triphosphate (ATP) Swab Test Market

Market Introduction

The ATP test is the fast calculation by identification of adenosine triphosphate or ATP of aggressively developing microorganisms. ATP is a molecule in and near living cells that specifically tests the biological production and wellbeing of the organisms. ATP is determined with the natural fire enzyme luciferase by using a luminometer to calculate the light emitted by its reaction.

Market Overview and Dynamics

The South and Central America Adenosine Triphosphate (ATP) swab test market is expected to reach US$ 17.67 million by 2027 from US$ 10.45 million in 2019. The market is estimated to grow at a CAGR of 6.9% from 2020 to 2027. The growth of the market is attributed to the key driving factors such as rising prevalence of healthcare associated infections (HAI) and increasing emphasis on food safety. However, the limitations of ATP swab tests hinder the market growth.

Key Market Segments

The South and Central America Adenosine Triphosphate (ATP) Swab Test market, based on type, is segmented into free ATP test and microbial ATP test. In 2019, the microbial ATP test segment held a larger market share, and the market for the same segment is expected to grow at a faster rate during the coming years.

The South and Central America Adenosine Triphosphate (ATP) Swab Test market, based on the application, is segmented into pharmaceutical & biotechnology company, food & beverage, hospitals & diagnostics laboratories, and academic & research institutions. In 2019, the pharmaceutical & biotechnology company segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest rate during the coming years.

Major Sources and Companies Listed

A Few of the primary and secondary sources associated with this report on the South and Central America Adenosine Triphosphate (ATP) swab test market are the American Society of Testing and Material (ASTM), Centers for Disease Control and Prevention (CDC) and National Health Service (NHS).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of the South and Central America Adenosine Triphosphate (ATP) swab test market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the South and Central America Adenosine Triphosphate (ATP) swab test market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the South and Central America Adenosine Triphosphate (ATP) swab test market.

SOUTH AND CENTRAL AMERICA ADENOSINE TRIPHOSPHATE (ATP) SWAB TEST MARKET SEGMENTATION

By Type

• Free ATP Test
• Microbial ATP Test

By Application

• Pharmaceutical and Biotechnology Company
• Food and Beverage
• Hospitals and Diagnostics Laboratories
• Academic and Research Institutions

By Country

• Brazil
• Argentina
• Rest of South and Central America

Company Profiles

• 3M
• Hygiena, LLC
• Charm Sciences
• Neogen Corporation
• Ecolab
• MERCK KGaA

South and Central America Adenosine Triphosphate (ATP) Swab Test Market Strategic Insights

South and Central America Adenosine Triphosphate (ATP) Swab Test Market Segmentation Analysis

South and Central America Adenosine Triphosphate (ATP) Swab Test Market Report Highlights

South and Central America Adenosine Triphosphate (ATP) Swab Test Report Scope

South and Central America Adenosine Triphosphate (ATP) Swab Test Market Country and Regional Insights